Search - tctmd.com

Displaying 61 - 80 of 267

Sort: Relevancy | Date

Presentation Miami Valves 2023

Evolution of the Management of Cardiogenic Shock

Presenter: David A. Baran

February 02, 2023

Presentation TCT 2022

TCT 603: Evolution of Alternative Access Approaches in a High-Volume TAVR Center

Presenter: Rohit Masih

September 19, 2022

Presentation TCT 2022

Patient Selection for PFO Closure in 2022: An Evolutionary Process

Presenter: Reda Ibrahim

September 18, 2022

Presentation TCT 2022

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

Presenter: Scott Lim

September 18, 2022

Presentation TCT 2022

Advances in Transcatheter Therapy for SMR: Imaging Evolution, Ventricular Remodeling, and Emerging Devices

Presenter: Azeem Latib

September 17, 2022

Presentation TCT 2022

EVOLUT: New Trials, New Technologies (OPTIMIZE PRO and SMART)

Presenter: John Forrest

September 17, 2022

Presentation TVT 2022

Patient Selection for PFO Closure in 2022: An Evolutionary Process

Presenter: Reda Ibrahim

June 10, 2022

Presentation TVT 2022

Proven Safety through MitraClip G4 and Evolution of TEER

Presenter: Rahul Sharma

June 09, 2022

Presentation TVT 2022

Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Latest-Generation Evolut PRO/PRO+: Insights From the NEOPRO and NEOPRO-2 Registries

Presenter: Andrea Scotti

June 09, 2022

Presentation TVT 2022

Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond

Presenter: John K. Forrest

June 08, 2022

Presentation TVT 2022

Evolution of Tricuspid Regurgitation Over Time Following Transvenous Pacemaker and Defibrillator Lead Implantation

Presenter: Marc Allard-Ratick

June 08, 2022

Presentation TVT 2022

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Presenter: Sreekanth Vemulapalli

June 08, 2022

Presentation TVT 2022

Transcatheter aortic valve implantation with zero contrast technique in chronic kidney disease population - Evolut - zero CKD Pilot study

Presenter: Pedro Nicz

June 08, 2022

Presentation Fellows 2022

The Evolution in PCI Pharmacology Over the Past 25 Years

Presenter: David Cohen

May 06, 2022

Presentation TVT 2021

PFO Device Evolution: Do We Need to Reduce the Anatomical Footprint?

Presenter: Horst Sievert

July 22, 2021

Presentation TVT 2021

TEER Device Evolution: Impact on Technical Success and Complications

Presenter: Anita Asgar

July 20, 2021

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk

Presenter: Michael Reardon

October 16, 2020

Presentation TCT 2020

Grading FMR Severity: Evolution of the Concept and Evolving Data

Presenter: Paul Grayburn

October 14, 2020

Presentation TCT 2020

TCT 507: We Present a Case Involving TAVI Using a Medtronik Evolut R. On Deployment of the Device, Both Coronaries Were Widely Patent and Position Appeared Good. Within 30 Minutes of Deployment, the Self-Expanding Nature of the Device Caused Obstruction…

Presenter: Matthew Mercieca Balbi

October 14, 2020

Presentation TCT 2020

TCT 473: Reproducibility of Cusp Overlap Technique to Reduce Permanent Pacemaker Implantation With Evolut – The Latin American Experience

Presenter: Hemal Gada

October 14, 2020

Advertisement

Evolution of the Management of Cardiogenic Shock

TCT 603: Evolution of Alternative Access Approaches in a High-Volume TAVR Center

Patient Selection for PFO Closure in 2022: An Evolutionary Process

TEER in Evolution – PASCAL in DMR; insights on data from CLASP IID RCT

Advances in Transcatheter Therapy for SMR: Imaging Evolution, Ventricular Remodeling, and Emerging Devices

EVOLUT: New Trials, New Technologies (OPTIMIZE PRO and SMART)

Patient Selection for PFO Closure in 2022: An Evolutionary Process

Proven Safety through MitraClip G4 and Evolution of TEER

Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Latest-Generation Evolut PRO/PRO+: Insights From the NEOPRO and NEOPRO-2 Registries

Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond

Evolution of Tricuspid Regurgitation Over Time Following Transvenous Pacemaker and Defibrillator Lead Implantation

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Transcatheter aortic valve implantation with zero contrast technique in chronic kidney disease population - Evolut - zero CKD Pilot study

The Evolution in PCI Pharmacology Over the Past 25 Years

PFO Device Evolution: Do We Need to Reduce the Anatomical Footprint?

TEER Device Evolution: Impact on Technical Success and Complications

TAVR in Low Surgical Risk Patients - Evidence Updates From Evolut Low-Risk

Grading FMR Severity: Evolution of the Concept and Evolving Data

TCT 507: We Present a Case Involving TAVI Using a Medtronik Evolut R. On Deployment of the Device, Both Coronaries Were Widely Patent and Position Appeared Good. Within 30 Minutes of Deployment, the Self-Expanding Nature of the Device Caused Obstruction…

TCT 473: Reproducibility of Cusp Overlap Technique to Reduce Permanent Pacemaker Implantation With Evolut – The Latin American Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content